News & Insights

Advisory
DEA Issues Public Safety Warning on Fentanyl and Emerging Synthetic Opioids
The U.S. Drug Enforcement Administration (DEA) has issued a new Public Safety Advisory warning communities, healthcare professionals, first
News & Insights
Executive Order Eases Federal Restrictions on Psychedelic Research
President Donald Trump’s recent executive order easing some federal restrictions on psychedelic substances is drawing
Medical Marijuana Rescheduling Marks Major Shift in U.S. Cannabis Policy
A major change in federal cannabis policy could reshape conversations across healthcare, pharmacy, addiction medicine, and
Opioid Overdose Risk Perceptions, Barriers, and Facilitators: Implications for Clinical Practice and Harm Reduction
This Journal of Addiction Medicine study examines how patients who use nonprescribed stimulants perceive opioid overdose risk
VA Study: Ozempic, Other GLP-1 Drugs May Fight Addiction Across Every Major Substance
A new VA-led study highlights the potential of GLP-1 receptor agonists—commonly used for diabetes and weight loss, including

All Content

Advisory
DEA Issues Public Safety Warning on Fentanyl and Emerging Synthetic Opioids
The U.S. Drug Enforcement Administration (DEA) has issued a new Public Safety Advisory warning communities, healthcare professionals, first
News & Insights
signing
Executive Order Eases Federal Restrictions on Psychedelic Research
President Donald Trump’s recent executive order easing some federal restrictions on psychedelic substances is drawing national attention to
News & Insights
Cannabis
Medical Marijuana Rescheduling Marks Major Shift in U.S. Cannabis Policy
A major change in federal cannabis policy could reshape conversations across healthcare, pharmacy, addiction medicine, and public policy
News & Insights
Naloxone
Opioid Overdose Risk Perceptions, Barriers, and Facilitators: Implications for Clinical Practice and Harm Reduction
This Journal of Addiction Medicine study examines how patients who use nonprescribed stimulants perceive opioid overdose risk and identifies
News & Insights
Petros Levounis, MD, MA, the new President of the American Psychiatric Association (APA)
HMP Global’s East Coast Symposium announces American Psychiatric Association President Petros Levounis joins speaker lineup as keynote
The November 3-5 meeting will provide behavioral health care professionals the latest, most effective addiction treatment strategies to
Press Release
GLP1s
VA Study: Ozempic, Other GLP-1 Drugs May Fight Addiction Across Every Major Substance
A new VA-led study highlights the potential of GLP-1 receptor agonists—commonly used for diabetes and weight loss, including semaglutide
News & Insights
Older Adult SUD
Aging and Addiction: Trends, Challenges, and Clinical Implications
A recent KSAT report highlights a growing but often overlooked epidemic of substance use disorders (SUDs) among older adults, emphasizing
News & Insights
Nitazines
Synthetic Opioids May Have Caused Hundreds More UK Deaths than Thought
New research from King’s College London indicates that deaths from nitazenes—a class of extremely potent synthetic opioids—are likely being
News & Insights
Microdosing Article
The Alarming Trend of Psychedelic Microdosing
A Washington Post/Dr. Leana Wen newsletter highlights a growing trend of psychedelic microdosing in the U.S., with an estimated 10 million
News & Insights
SUD Image
Drug Use Disorders a Growing Public Health Concern in the Americas, PAHO Study Finds
A new Pan American Health Organization (PAHO) study underscores that drug use disorders are a major and escalating public health challenge
News & Insights
Cannabis
An Update on the Behavioral and Neurobiological Effects of Cannabis Use in Adolescents: A Translational Perspective
In this authoritative translational review published in The American Journal of Psychiatry, leading researchers synthesize cutting-edge
News & Insights
Prevention
The Little-Known Program Contributing to a Decline in Overdose Deaths in the US
The Guardian’s December 28, 2025 analysis highlights an emerging public health contributor to the historic decline in U.S. overdose deaths
News & Insights
Back to top